BUD31 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	33 studies	29% ± 9%	Explore
fibroblast	27 studies	27% ± 11%	Explore
B cell	24 studies	23% ± 9%	Explore
CD8-positive, alpha-beta T cell	24 studies	27% ± 10%	Explore
T cell	23 studies	24% ± 7%	Explore
endothelial cell	23 studies	29% ± 12%	Explore
CD4-positive, alpha-beta T cell	21 studies	26% ± 10%	Explore
smooth muscle cell	20 studies	25% ± 7%	Explore
regulatory T cell	20 studies	25% ± 4%	Explore
classical monocyte	19 studies	25% ± 13%	Explore
pericyte	19 studies	25% ± 7%	Explore
ciliated cell	16 studies	43% ± 18%	Explore
monocyte	15 studies	23% ± 8%	Explore
non-classical monocyte	15 studies	32% ± 17%	Explore
macrophage	15 studies	23% ± 10%	Explore
gamma-delta T cell	15 studies	28% ± 13%	Explore
CD16-positive, CD56-dim natural killer cell, human	14 studies	30% ± 11%	Explore
epithelial cell	14 studies	36% ± 21%	Explore
connective tissue cell	13 studies	28% ± 7%	Explore
memory B cell	13 studies	23% ± 5%	Explore
basal cell	12 studies	31% ± 14%	Explore
naive B cell	12 studies	22% ± 6%	Explore
endothelial cell of lymphatic vessel	11 studies	28% ± 8%	Explore
CD16-negative, CD56-bright natural killer cell, human	11 studies	31% ± 8%	Explore
mature NK T cell	11 studies	28% ± 6%	Explore
CD8-positive, alpha-beta memory T cell	10 studies	28% ± 11%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	10 studies	24% ± 8%	Explore
conventional dendritic cell	10 studies	31% ± 19%	Explore
capillary endothelial cell	10 studies	21% ± 5%	Explore
plasmacytoid dendritic cell	10 studies	22% ± 9%	Explore
endothelial cell of vascular tree	10 studies	27% ± 6%	Explore
mast cell	9 studies	20% ± 4%	Explore
mucosal invariant T cell	9 studies	24% ± 4%	Explore
myofibroblast cell	8 studies	28% ± 7%	Explore
abnormal cell	8 studies	34% ± 15%	Explore
vein endothelial cell	8 studies	23% ± 6%	Explore
plasma cell	7 studies	30% ± 11%	Explore
CD4-positive, alpha-beta memory T cell	7 studies	24% ± 7%	Explore
secretory cell	7 studies	25% ± 11%	Explore
effector CD8-positive, alpha-beta T cell	7 studies	28% ± 6%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	7 studies	23% ± 7%	Explore
effector memory CD8-positive, alpha-beta T cell	7 studies	30% ± 13%	Explore
endothelial cell of artery	7 studies	23% ± 4%	Explore
goblet cell	7 studies	26% ± 15%	Explore
myeloid cell	7 studies	25% ± 13%	Explore
plasmablast	6 studies	40% ± 23%	Explore
effector CD4-positive, alpha-beta T cell	6 studies	26% ± 5%	Explore
kidney loop of Henle epithelial cell	6 studies	23% ± 4%	Explore
epithelial cell of proximal tubule	6 studies	24% ± 7%	Explore
precursor B cell	6 studies	31% ± 11%	Explore
innate lymphoid cell	6 studies	28% ± 6%	Explore
T follicular helper cell	6 studies	25% ± 3%	Explore
leukocyte	5 studies	30% ± 9%	Explore
progenitor cell	5 studies	21% ± 6%	Explore
effector memory CD4-positive, alpha-beta T cell	5 studies	29% ± 12%	Explore
type I pneumocyte	4 studies	31% ± 11%	Explore
hematopoietic precursor cell	4 studies	35% ± 17%	Explore
deuterosomal cell	4 studies	28% ± 5%	Explore
mononuclear phagocyte	4 studies	28% ± 13%	Explore
exhausted T cell	4 studies	36% ± 13%	Explore
enteroendocrine cell	4 studies	36% ± 17%	Explore
mesothelial cell	4 studies	39% ± 19%	Explore
immature B cell	4 studies	20% ± 3%	Explore
neuron	4 studies	37% ± 18%	Explore
luminal hormone-sensing cell of mammary gland	4 studies	27% ± 3%	Explore
dendritic cell	4 studies	43% ± 25%	Explore
T-helper 17 cell	4 studies	26% ± 9%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	4 studies	20% ± 3%	Explore
squamous epithelial cell	3 studies	37% ± 24%	Explore
pancreatic A cell	3 studies	55% ± 12%	Explore
type B pancreatic cell	3 studies	42% ± 19%	Explore
glomerular endothelial cell	3 studies	17% ± 0%	Explore
kidney distal convoluted tubule epithelial cell	3 studies	32% ± 3%	Explore
renal alpha-intercalated cell	3 studies	31% ± 2%	Explore
neural crest cell	3 studies	28% ± 4%	Explore
lymphocyte	3 studies	35% ± 10%	Explore
club cell	3 studies	28% ± 4%	Explore
enterocyte	3 studies	20% ± 3%	Explore
pro-B cell	3 studies	25% ± 1%	Explore
type II pneumocyte	3 studies	36% ± 17%	Explore
amacrine cell	3 studies	35% ± 11%	Explore
intraepithelial lymphocyte	3 studies	26% ± 9%	Explore
CD4-positive helper T cell	3 studies	26% ± 8%	Explore
erythroblast	3 studies	36% ± 23%	Explore
germinal center B cell	3 studies	27% ± 2%	Explore
oligodendrocyte precursor cell	3 studies	24% ± 6%	Explore
group 3 innate lymphoid cell	3 studies	35% ± 14%	Explore
T-helper 1 cell	3 studies	30% ± 6%	Explore
double negative thymocyte	3 studies	37% ± 15%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	14 studies	28% ± 11%	Explore
lung	13 studies	29% ± 10%	Explore
kidney	8 studies	22% ± 4%	Explore
intestine	7 studies	25% ± 12%	Explore
liver	5 studies	27% ± 20%	Explore
lymph node	5 studies	26% ± 8%	Explore
bone marrow	4 studies	19% ± 3%	Explore
eye	4 studies	27% ± 9%	Explore
uterus	4 studies	33% ± 17%	Explore
breast	4 studies	24% ± 1%	Explore
pancreas	3 studies	45% ± 18%	Explore
adrenal gland	3 studies	25% ± 7%	Explore
prostate	3 studies	20% ± 5%	Explore
skin	3 studies	21% ± 4%	Explore
brain	3 studies	22% ± 8%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
esophagus	100%	1216.28	1445 / 1445	100%	41.73	183 / 183
ovary	100%	1067.67	180 / 180	100%	62.79	430 / 430
stomach	100%	1004.25	359 / 359	100%	42.90	286 / 286
uterus	100%	1105.96	170 / 170	100%	47.66	459 / 459
brain	100%	1260.01	2641 / 2642	100%	56.12	705 / 705
skin	100%	1489.87	1808 / 1809	100%	52.13	472 / 472
kidney	100%	1347.70	89 / 89	100%	37.12	900 / 901
thymus	100%	1260.56	653 / 653	100%	43.66	604 / 605
lung	100%	1271.86	578 / 578	100%	47.43	1153 / 1155
prostate	100%	1192.60	245 / 245	100%	41.56	501 / 502
breast	100%	1391.45	459 / 459	100%	44.35	1115 / 1118
pancreas	100%	550.75	327 / 328	100%	39.42	178 / 178
liver	100%	595.98	225 / 226	100%	27.26	406 / 406
intestine	100%	1174.54	966 / 966	99%	44.93	524 / 527
bladder	100%	1163.62	21 / 21	99%	47.35	500 / 504
adrenal gland	100%	1256.66	258 / 258	99%	36.78	228 / 230
adipose	100%	1369.03	1204 / 1204	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	58.12	29 / 29
spleen	100%	1133.96	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	43.60	45 / 45
ureter	0%	0	0 / 0	100%	24.74	1 / 1
blood vessel	100%	1379.08	1334 / 1335	0%	0	0 / 0
eye	0%	0	0 / 0	99%	30.97	79 / 80
muscle	98%	545.78	789 / 803	0%	0	0 / 0
heart	98%	709.15	845 / 861	0%	0	0 / 0
peripheral blood	98%	1145.46	909 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0000398	Biological process	mRNA splicing, via spliceosome
GO_0045893	Biological process	positive regulation of DNA-templated transcription
GO_2000825	Biological process	positive regulation of androgen receptor activity
GO_0005654	Cellular component	nucleoplasm
GO_0000785	Cellular component	chromatin
GO_0071007	Cellular component	U2-type catalytic step 2 spliceosome
GO_0005681	Cellular component	spliceosomal complex
GO_0005634	Cellular component	nucleus
GO_0016922	Molecular function	nuclear receptor binding
GO_0030374	Molecular function	nuclear receptor coactivator activity
GO_0005515	Molecular function	protein binding

Gene name	BUD31
Protein name	Protein BUD31 homolog BUD31 homolog Protein BUD31 homolog (Protein EDG-2) (Protein G10 homolog)
Synonyms	EDG2
Description	FUNCTION: Involved in the pre-mRNA splicing process . May play a role as regulator of AR transcriptional activity; may increase AR transcriptional activity . .
Accessions	ENST00000222969.10 [P41223-1] C9JCD9 F8WCN7 ENST00000456893.6 P41223 ENST00000403633.6 [P41223-1] ENST00000427499.5

BUD31 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review